Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 157Carcinoma, Intraductal, Noninfiltrating 16Breast Carcinoma In Situ 12Neoplasm Metastasis 9Ovarian Neoplasms 7Breast Neoplasms, Male 7Neoplasms 4Prostatic Neoplasms 3Inflammatory Breast Neoplasms 3Glioblastoma 3Breast Cancer Female 3Urinary Bladder Neoplasms 2Recurrence 2Pancreatic Neoplasms 2Obesity 2Infertility 2Hot Flashes 2Fibroadenoma 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2ER+ Breast Cancer 2Brain Neoplasms 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Sleep Wake Disorders 1Sexuality 1Risk Reduction Behavior 1Rhabdoid Tumor 1Pyloric Stenosis, Hypertrophic 1Primary Breast Cancer 1

Interventions

Radiotherapy 3Cisplatin 2tislelizumab 1pembrolizumab 1Tamoxifen 1TP protocol 1Spinal Puncture 1Radiosurgery 1Paclitaxel 1Oxaliplatin 1Irinotecan 1Gemcitabine 1Gadolinium 1Fluorouracil 1Ethiodized Oil 1Cetuximab 1Carboplatin 1Blood Specimen Collection 1Anesthesia, General 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplasm Recurrence, Local × Tamoxifen × Clear all
NCT01357772 2023-07-17

TAM-01

Ente Ospedaliero Ospedali Galliera

Phase 3 Active not recruiting
500 enrolled
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Neoplasm Recurrence, Local

Data powered by HemOnc (CC BY 4.0) Colophon âš¡